SCHEMBL24349591

SCHEMBL24349591

CNC(C)(C)c1cnc2ccccn12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 1/20 0.54
NPSR1 Q6W5P4 2/20 0.42
IRAK4 Q9NWZ3 5/20 0.41
FLT3 P36888 2/20 0.41
NPC1 O15118 3/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 3/20 0.41
KDM4E B2RXH2 1/20 0.41
GLA P06280 1/20 0.41
GAA P10253 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ADORA3 P0DMS8 1/20 0.40
GGPS1 O95749 1/20 0.39
FDPS P14324 1/20 0.39
DYRK1A Q13627 1/20 0.39
MIF P14174 1/20 0.39
TP53 P04637 2/20 0.38
RAB9A P51151 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9609560 0.84 SSTR4 (0.48) SSTR4NPSR1IRAK4FLT3NPC1
SCHEMBL24348667 0.83 SSTR4 (0.44) SSTR4NPSR1IRAK4FLT3ALDH1A1
SCHEMBL9537296 0.81 SSTR4 (0.46) SSTR4NPSR1IRAK4FLT3NPC1
SCHEMBL27221248 0.81 SSTR4 (0.49) SSTR4NPSR1FLT3NPC1ALDH1A1
SCHEMBL21554029 0.79 SSTR4 (0.46) SSTR4NPSR1IRAK4FLT3NPC1
SCHEMBL12463958 0.78 SSTR4 (0.44) SSTR4NPSR1IRAK4FLT3NPC1
SCHEMBL24348668 0.76 GGPS1 (0.46) SSTR4NPSR1FLT3NPC1ALDH1A1
SCHEMBL24348662 0.76 SSTR4 (0.43) SSTR4NPSR1IRAK4FLT3ADORA3
SCHEMBL20439080 0.76 SSTR4 (0.45) SSTR4NPSR1IRAK4FLT3NPC1
SCHEMBL24348738 0.74 SSTR4 (0.80) SSTR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022058745-A9 IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THEIR USE IN THERAPY IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2022-05-27 WO disclosed
WO-2022058745-A2 NOVEL COMPOUNDS AND THEIR USE IN THERAPY IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2022-03-24 WO disclosed